Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.

Costa CD, Justo AA, Kobayashi PE, Story MM, Palmieri C, Laufer Amorim R, Fonseca-Alves CE.

Int J Biochem Cell Biol. 2019 Jan 8;108:21-28. doi: 10.1016/j.biocel.2019.01.002. [Epub ahead of print]

PMID:
30633985
2.

Optimization based trajectory planning for real-time 6DoF robotic patient motion compensation systems.

Liu X, Wiersma RD.

PLoS One. 2019 Jan 11;14(1):e0210385. doi: 10.1371/journal.pone.0210385. eCollection 2019.

3.

Cancer metabolism in a snapshot: MRS(I).

Julià-Sapé M, Candiota AP, Arús C.

NMR Biomed. 2019 Jan 11:e4054. doi: 10.1002/nbm.4054. [Epub ahead of print] Review.

PMID:
30633389
4.

Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?

Cole AP, Fletcher SA, Berg S, Nabi J, Mahal BA, Sonpavde GP, Nguyen PL, Lipsitz SR, Sun M, Choueiri TK, Preston MA, Kibel AS, Trinh QD.

Cancer. 2019 Jan 11. doi: 10.1002/cncr.31926. [Epub ahead of print]

PMID:
30633323
5.

Acupuncture for pain caused by prostate cancer: Protocol for a systematic review.

Wang J, Lei Y, Bao B, Yu X, Dai H, Chen F, Li H, Wang B.

Medicine (Baltimore). 2019 Jan;98(2):e13954. doi: 10.1097/MD.0000000000013954.

6.

Facility-Level Variation In Rates Of Definitive Therapy For Low-Risk Prostate Cancer Among Men With Limited Life Expectancy: An Opportunity For Value-Based Care Redesign.

Friedlander DF, von Landenberg N, Löppenberg B, Noldus J, Lipsitz SR, Cole AP, Abdollah F, Nguyen PL, Choueiri TK, Kibel AS, Trinh QD.

J Urol. 2018 Dec 24. doi: 10.1097/JU.0000000000000006. [Epub ahead of print]

PMID:
30633112
7.

Incidence of surgical interventions for metastatic bone disease in the extremities: a population-based cohort study.

Skovlund Sørensen M, Hindsø K, Frederik Horstmann P, Troelsen A, Dalsgaard S, Fog T, Zimnicki T, Mørk Petersen M.

Acta Oncol. 2019 Jan 11:1-7. doi: 10.1080/0284186X.2018.1549368. [Epub ahead of print]

PMID:
30632859
8.

UNC5D, suppressed by promoter hypermethylation, inhibits cell metastasis by activating DAPK1 in prostate cancer.

Dong D, Zhang L, Bai C, Ma N, Ji W, Jia L, Zhang A, Zhang P, Ren L, Zhou Y.

Cancer Sci. 2019 Jan 11. doi: 10.1111/cas.13935. [Epub ahead of print]

9.

Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Hamada T, Nowak JA, Milner DA Jr, Song M, Ogino S.

J Pathol. 2019 Jan 11. doi: 10.1002/path.5236. [Epub ahead of print] Review.

PMID:
30632609
10.

Rubber Band Ligation of Hemorrhoids is often a Necessary Complement in the Management of Hemorrhagic Radiation Proctitis.

De Robles MS, Young CJ.

Scand J Surg. 2019 Jan 11:1457496918822619. doi: 10.1177/1457496918822619. [Epub ahead of print]

PMID:
30632450
11.

INFECTIOUS COMPLICATIONS OF CONVENTIONAL LAPAROSCOPIC VERSUS ROBOTIC LAPAROSCOPIC PROSTATECTOMY: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS.

Marra AR, Puig-Asensio M, Edmond MB, Schweizer ML, Nepple KG.

J Endourol. 2019 Jan 11. doi: 10.1089/end.2018.0815. [Epub ahead of print]

PMID:
30632396
12.

Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells.

Chen W, Allen SG, Qian W, Peng Z, Han S, Li X, Sun Y, Fournier C, Bao L, Lam RHW, Merajver SD, Fu J.

Small. 2019 Jan 11:e1802891. doi: 10.1002/smll.201802891. [Epub ahead of print]

PMID:
30632269
13.

COUNTERPOINT-Prostate Cancer Genomic Analysis: Routine or Research Only?

Kelly WK, Knudsen KE.

Oncology (Williston Park). 2018 Dec 17;32(12). pii: 620318. No abstract available.

14.

POINT-Prostate Cancer Genomic Analysis: Routine or Research Only?

Bernard B, Flaig TW.

Oncology (Williston Park). 2018 Dec 17;32(12). pii: 620317. No abstract available.

15.

Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer.

Kittai AS, Blank J, Graff JN.

Oncology (Williston Park). 2018 Dec 17;32(12). pii: 620315.

16.

Author Correction: Drier Climatic Conditions Increase Withanolide Content of Withania coagulans Enhancing its Inhibitory Potential against Human Prostate Cancer Cells.

Rehman S, Keefover-Ring K, Haq IU, Dilshad E, Khan MI, Akhtar N, Mirza B.

Appl Biochem Biotechnol. 2019 Jan 10. doi: 10.1007/s12010-018-02941-8. [Epub ahead of print]

PMID:
30632062
17.

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers.

Collery P, Veena V, Harikrishnan A, Desmaele D.

Invest New Drugs. 2019 Jan 11. doi: 10.1007/s10637-019-00727-1. [Epub ahead of print]

PMID:
30632005
18.

Resonance assignment of human LARP4A La module.

Cruz-Gallardo I, Martino L, Trotta R, De Tito S, Kelly G, Atkinson RA, Randazzo A, Conte MR.

Biomol NMR Assign. 2019 Jan 10. doi: 10.1007/s12104-019-09871-4. [Epub ahead of print]

PMID:
30632004
19.

Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients.

Sandgren K, Johansson L, Axelsson J, Jonsson J, Ögren M, Ögren M, Andersson M, Strandberg S, Nyholm T, Riklund K, Widmark A.

EJNMMI Phys. 2019 Jan 11;6(1):2. doi: 10.1186/s40658-018-0239-2.

PMID:
30631980
20.

High sulfite oxidase expression could predict postoperative biochemical recurrence in patients with prostate cancer.

Kurose H, Naito Y, Akiba J, Kondo R, Ogasawara S, Kusano H, Sanada S, Abe H, Kakuma T, Ueda K, Igawa T, Yano H.

Med Mol Morphol. 2019 Jan 10. doi: 10.1007/s00795-018-00214-1. [Epub ahead of print]

PMID:
30631948

Supplemental Content

Loading ...
Support Center